Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMYOTROPHIC LATERAL SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05866926
What this trial is testing

Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Ferrer Internacional S.A. 201
Testing effectiveness (Phase 2)Study completedNCT01806857
What this trial is testing

Clinical Trial Nuedexta in Subjects With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Center for Neurologic Study, La Jolla, California, 90
Early research (Phase 1)Study completedNCT03945279
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 49
Not applicableStudy completedNCT00023075
What this trial is testing

Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis

Who this might be right for
Primary Lateral SclerosisHereditary Spastic ParaplegiaAmyotrophic Lateral Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 55
Large-scale testing (Phase 3)Ended earlyNCT05442775
What this trial is testing

A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 71
Not applicableUnknownNCT01530438
What this trial is testing

Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Caen 90
Early research (Phase 1)Looking for participantsNCT07290062
What this trial is testing

Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Insmed Gene Therapy LLC 23
Testing effectiveness (Phase 2)Study completedNCT02714036
What this trial is testing

A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
MediciNova 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07813858
What this trial is testing

Colchicine Effect on Amyotrophic Lateral Sclerosis Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Azienda Ospedaliero-Universitaria di Modena 87
Testing effectiveness (Phase 2)Study completedNCT01232738
What this trial is testing

Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Yunxia Wang, MD 36
Early research (Phase 1)Ended earlyNCT03757351
What this trial is testing

Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Sanofi 15
Not applicableLooking for participantsNCT04454892
What this trial is testing

Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT01363401
What this trial is testing

Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisALS
Corestemchemon, Inc. 72
Not applicableStudy completedNCT01592552
What this trial is testing

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Who this might be right for
Alzheimer's DiseaseMultiple SclerosisParkinson's Disease+2 more
Sanguine Biosciences 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06392126
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
n-Lorem Foundation 1
Large-scale testing (Phase 3)Study completedNCT04577404
What this trial is testing

Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Shionogi 124
Not applicableStudy completedNCT05407428
What this trial is testing

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
NeuraLight 45
Testing effectiveness (Phase 2)Study completedNCT02039401
What this trial is testing

Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Helixmith Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07294144
What this trial is testing

Tofersen in Non-SOD1 ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT04499963
What this trial is testing

Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Richard Bedlack, M.D., Ph.D. 100
Next Page